Alkem Laboratories

Pharmaceuticals
Current Valuation
N/A
As of December 7, 2015
Total Funding Raised
N/A
Across 1 round
Last Round
PE Growth/Expansion

$60.0M

Last Funding
Dec 2015

Funding date

Capital Efficiency
N/A

Valuation / Funding

Interested in buying or selling Alkem Laboratories shares?

Get a free quote from our secondary market team. We facilitate transactions from $250K to $500M+.

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
December 7, 2015PE Growth/Expansion$60.0MN/A-
Valuation Analysis

Current Valuation Metrics

Alkem Laboratories is currently valued at N/A as of December 7, 2015.

Explore More Data
Detailed analysis for Alkem Laboratories

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

See full funding history

Sign up to view Alkem Laboratories's complete funding timeline, round details, and valuation progression.

What is Alkem Laboratories Worth in 2026?

Alkem Laboratories is a leading private company in the Pharmaceuticals sector. Track Alkem Laboratories's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Alkem Laboratories Valuation is Determined

Private company valuations like Alkem Laboratories's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.